Skip to main content
. Author manuscript; available in PMC: 2021 Aug 2.
Published in final edited form as: Gynecol Oncol. 2018 Jun 29;150(3):451–459. doi: 10.1016/j.ygyno.2018.06.020

Figure 2.

Figure 2.

Figure 2.

Estimated product-limit survival rates of 1:1 matched ovarian cancer patients stratified by stage. (Figure 2a) Stage III, n = 1,296; (Figure 2b) Stage IV, n = 950)